Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry

被引:0
作者
Sammour, Yasser M. [1 ]
Spertus, John A. [2 ,3 ]
Kennedy, Kevin [2 ,3 ]
Morrow, David A. [4 ]
Daniels, Lori B. [5 ]
Jones, Phil [2 ,3 ]
Alger, Heather [6 ]
Stevens, Laura [6 ]
Shah, Alpesh [1 ]
Goel, Sachin S. [1 ]
Lemos, James A. de [7 ]
Hayek, Salim S. [8 ]
Sutton, Nadia R. [9 ]
Kleiman, Neal S. [1 ,10 ]
机构
[1] Houston Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA
[2] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[3] Univ Missouri Kansas City, Kansas City, MO USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Cardovasc Div, Boston, MA USA
[5] Univ Calif San Diego, La Jolla, CA USA
[6] Amer Heart Assoc, Data Solut & Res Qual & Hlth IT, Framingham, MA USA
[7] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[8] Michigan Med, Div Cardiovasc Med, Ann Arbor, MI USA
[9] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[10] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Sect Intervent Cardiol, 6565 Fannin,MS WT-4-3020, Houston, TX 77030 USA
来源
AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE | 2023年 / 27卷
关键词
COVID-19; Myocardial injury; Troponin elevation; Coronary angiography; AHA COVID-19 CVD registry; INFARCTION; MANAGEMENT; TROPONIN;
D O I
10.1016/j.ahjo.2023.100265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated cardiac troponin (cTn) levels in patients with COVID-19 has been associated with worse outcomes. Guidelines on best practices of those patients remain uncertain.Methods: We included patients with COVID-19 and cTn above the assay-specific upper limit of normal (ULN) enrolled in the American Heart Association's COVID-19 registry between March 2020-January 2021. Site-level variability in invasive coronary angiography, LVEF assessment, ICU utilization, and inpatient mortality were determined by calculating adjusted median odds ratio (MOR) using hierarchical logistic regression models. Temporal trends were assessed with Cochran-Armitage trend test.Results: Among 32,636 patients, we included 6234 (19.4 %) with cTn above ULN (age 68.7 +/- 16.0 years, 56.5 % male, 51.5 % Caucasian), of whom 1365 (21.6 %) had >= 5-fold elevations. Across 55 sites, the median rate of invasive coronary angiography was 0.1 % with adjusted MOR 1.5(1.0,2.3), median LVEF assessment was 25.5 %, MOR 3.0(2.2,3.9), ICU utilization was 41.7 %, MOR 2.2(1.8,2.6), and mortality was 20.9 %, MOR 1.7(1.5,2.0). Over time, we noted a significant increase in invasive coronary angiography (p-trend = 0.001), and LVEF assessment (p-trend<0.001), and reduction in mortality (p-trend<0.001), without significant change in ICU admissions (p-trend = 0.08). Similar variability and temporal trends were seen among patients with >= 5-fold cTn elevation.Conclusions: The use of invasive coronary angiography among patients with COVID-19 and myocardial injury was very low during the early pandemic. We found moderate institutional variability in processes of care with an uptrend in invasive catheterization and LVEF assessment, and downtrend in mortality. Comparative effectiveness studies are needed to examine whether variability in care is associated with differences in outcomes.
引用
收藏
页数:9
相关论文
共 21 条
  • [1] American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines
    Alger, Heather M.
    Rutan, Christine
    Williams, Joseph H.
    Walchok, Jason G.
    Bolles, Michele
    Hall, Jennifer L.
    Bradley, Steven M.
    Elkind, Mitchell S. V.
    Rodriguez, Fatima
    Wang, Tracy Y.
    Morrow, David A.
    Das, Sandeep R.
    de Lemos, James A.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (08): : E006967
  • [2] Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry
    Bhatt, Ankeet S.
    Varshney, Anubodh S.
    Goodrich, Erica L.
    Gong, Jingyi
    Ginder, Curtis
    Senman, Balimkiz C.
    Johnson, Matthew
    Butler, Kayleigh
    Woolley, Ann E.
    de Lemos, James A.
    Morrow, David A.
    Bohula, Erin A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (09):
  • [3] Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic
    Case, Brian C.
    Abramowitz, Jonathan
    Shea, Corey
    Rappaport, Hank
    Yerasi, Charan
    Forrestal, Brian J.
    Chezar-Azerrad, Chava
    Medranda, Giorgio A.
    Zhang, Cheng
    Satler, Lowell F.
    Ben-Dor, Itsik
    Hashim, Hayder
    Rogers, Toby
    Weintraub, William S.
    Waksman, Ron
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 157 : 42 - 47
  • [4] Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia JACC Focus Seminar
    Giustino, Gennaro
    Pinney, Sean P.
    Lala, Anuradha
    Reddy, Vivek Y.
    Johnston-Cox, Hillary A.
    Mechanick, Jeffrey, I
    Halperin, Jonathan L.
    Fuster, Valentin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : 2011 - 2023
  • [5] Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
    Hirschfeld, Cole B.
    Shaw, Leslee J.
    Williams, Michelle C.
    Lahey, Ryan
    Villines, Todd C.
    Dorbala, Sharmila
    Choi, Andrew D.
    Shah, Nishant R.
    Bluemke, David A.
    Berman, Daniel S.
    Blankstein, Ron
    Ferencik, Maros
    Narula, Jagat
    Winchester, David
    Malkovskiy, Eli
    Goebel, Benjamin
    Randazzo, Michael J.
    Lopez-Mattei, Juan
    Parwani, Purvi
    Vitola, Joao V.
    Cerci, Rodrigo J.
    Better, Nathan
    Raggi, Paolo
    Lu, Bin
    Sergienko, Vladimir
    Sinitsyn, Valentin
    Kudo, Takashi
    Norgaard, Bjarne Linde
    Maurovich-Horvat, Pal
    Cohen, Yosef A.
    Pascual, Thomas N. B.
    Pynda, Yaroslav
    Dondi, Maurizio
    Paez, Diana
    Einstein, Andrew J.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2021, 14 (09) : 1787 - 1799
  • [6] Kontos M., 2020, Poll Results: NSTEMI in the COVID-Positive Patient
  • [7] The Clinical Challenge of ST-Segment Elevation Myocardial Infarction and COVID-19
    Kornowski, Ran
    Orvin, Katia
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (16) : 2004 - 2006
  • [8] Patterns ofmyocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
    Kotecha, Tushar
    Knight, Daniel S.
    Razvi, Yousuf
    Kumar, Kartik
    Vimalesvaran, Kavitha
    Thornton, George
    Patel, Rishi
    Chacko, Liza
    Brown, James T.
    Coyle, Clare
    Leith, Donald
    Shetye, Abhishek
    Ariff, Ben
    Bell, Robert
    Captur, Gabriella
    Coleman, Meg
    Goldring, James
    Gopalan, Deepa
    Heightman, Melissa
    Hillman, Toby
    Howard, Luke
    Jacobs, Michael
    Jeetley, Paramjit S.
    Kanagaratnam, Prapa
    Kon, Onn Min
    Lamb, Lucy E.
    Manisty, Charlotte H.
    Mathurdas, Palmira
    Mayet, Jamil
    Negus, Rupert
    Patel, Niket
    Pierce, Iain
    Russell, Georgina
    Wolff, Anthony
    Xue, Hui
    Kellman, Peter
    Moon, James C.
    Treibel, Thomas A.
    Cole, Graham D.
    Fontana, Marianna
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (19) : 1866 - 1878
  • [9] Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702]
  • [10] Management of acute myocardial infarction during the COVID-19 pandemic A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)
    Mahmud, Ehtisham
    Dauerman, Harold L.
    Welt, Frederick G. P.
    Messenger, John C.
    Rao, Sunil, V
    Grines, Cindy
    Mattu, Anna
    Kirtane, Ajay J.
    Jauhar, Rajiv
    Meraj, Perwaiz
    Rokos, Ivan C.
    Rumsfeld, John S.
    Henry, Timothy D.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (02) : 336 - 345